LONG-TERM ADMINISTRATION OF PROLACTIN OR TESTOSTERONE INDUCED SIMILAR PRECANCEROUS PROSTATE LESIONS IN RATS

Deissy Herrera‐Covarrubias, Genaro A. Coria‐Ávila, P Chavarría-Xicoténcatl, Cynthia Fernández–Pomares, Jorge Manzo, Gonzálo Emiliano Aranda-Abreu

Experimental Oncology · 2015 · 18 citations · 33 references

Concepts

Abstract

UNLABELLED: Evidence indicates that prolactin plays a crucial role in the normal function and development of the prostate, but abnormal high levels of the hormone are associated with hyperplasia and cancer of the gland. AIMS: The present study was designed to describe the progressive specific histological abnormalities in the prostate of rats with chronic hyperprolactinemia. MATERIAL AND METHODS: Prolactin was administered during 4; 12 or 24 weeks, and the resulting prostatic alterations were compared with control rats, and also with those treated with testosterone, or the combination of prolactin + testosterone. RESULTS: Rats treated with prolactin, testosterone or prolactin + testosterone expressed precancerous histological abnormalities in the dorsolateral and ventral portions of the prostate as early as in 4 weeks of treatment, but in all cases the malignancy increased after 12 or 24 weeks of treatment. CONCLUSION: Our study confirms that chronic hyperprolactinemia is a cause of prostate precancerous pathologies.

References

33